DATROWAY Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic TNBC Who Are Not Candidates ...

The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan-dlnk) has been accepted and granted Priority Review in the US for the treatment ...

Researchers have developed a new biomimetic nanocomposite (mPDA-Cas9) for treating triple-negative breast cancer (TNBC) by combining CRISPR/Cas9 gene ...

Purdue researchers identify the PACT protein as a potential target for triple-negative breast cancer, opening new paths for future treatments.

A Purdue University team has discovered a new therapeutic target for triple-negative breast cancer. The research, led by Kyle ...

Louisiana is making strides in breast cancer research, specifically focusing on triple-negative breast cancer. This type of cancer is known for occurring at an earlier age, spreading ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

In this video, Azka Ali, MD, medical oncologist at the Cleveland Clinic Taussig Cancer Institute, highlights interesting ...

The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology to include ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...